市场概况

The global vitamin D market is expected to rise by USD 76.3 百万，复合年增长率为 5.3% 到年底 2029. Key drivers of this growth include its application in nutricosmetics, premixes, functional beverages, and the vegan sector. The market is highly competitive, with clinically proven formulas and scientific research being crucial for product differentiation. Vitamin D deficiency affects over 1 billion people worldwide due to inadequate diet and sunlight exposure, with factors like geography and demographics playing a role. The demand for supplements and functional foods has increased during the COVID-19 pandemic, driven by nutrition requirements, government initiatives, and industry investments. Vitamin D has been extensively studied for its impact on biological processes and its associations with illnesses such as cancer and autoimmune diseases. Topical skincare products containing vitamin D, especially those with 5,000 IU, have gained recognition for their therapeutic effects on conditions like psoriasis. Vitamin D insufficiency is a widespread condition globally, leading to poor bone health and increased risks of various diseases. Increased awareness of the importance of vitamin D contributes to the market’s growth.

该报告涵盖了市场规模和增长, 分割, 竞争格局, trends and strategies for global vitamin d market. 它提供了对市场的定量分析，使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

市场细分

市场根据多种因素进行细分, including analog, 形式, 应用, 最终用户, 和地理.

按应用细分
药品
Animal Health
Functional Food and Beverages
个人护理

Segmentation by Form
Dry
Liquid

Segmentation by Analog
Vitamin D2
维生素D3

Segmentation by End User
Humans
Animals

按地理位置细分
北美 – 美国, 加拿大
Europe – Germany, 法国, 英国, 意大利, 西班牙, 俄罗斯, 波兰
亚太地区 – 中国, 日本, 印度, 韩国, 澳大利亚, 印度尼西亚, 越南, 泰国, 马来西亚
拉丁美洲 – 巴西, 墨西哥, 阿根廷, Columbia
中东 & 非洲 – 南非, 沙特阿拉伯, 火鸡

在 2022, the pharmaceuticals segment held a 48.4% share in the global vitamin D market, driven by its application in vitamin therapy and beauty supplements. Vitamin D plays a crucial role in calcium absorption and bone growth, making it essential for pharmaceutical companies. Deficiencies and medical complications related to vitamin D contribute to its importance. Dry vitamin D holds a dominant share of 71.7% due to its stability and extended shelf life. The vitamin D3 segment holds a significant share of 69.8% as it is the biologically active form found in humans and animals. The human segment is the largest end-user category at 67.1% due to the need for supplementation. Europe holds a significant share of 28.2% due to nutricosmetics, changing lifestyles, and the presence of pharmaceutical companies. Vitamin D deficiency is prevalent in Europe, making it a strong market. The growing vegan population poses challenges but also drives demand for vegan-enriched products. The COVID-19 pandemic has increased vitamin D supplement sales in Spain.

竞争格局

The vitamin D market includes BASF SE, Bluestar Adisseo Co., Dishman Carbogen Amcis Ltd., Divi’s Laboratories Ltd., 福门达生物科技有限公司, Jiangxi Tianxin Pharmaceutical Co., 有限公司, 皇家帝斯曼公司, LycoRed Ltd., Sichuan Neijiang Huixin Pharmacy Co., 有限公司, 厦门金达威集团公司, 浙江花园生化高科技有限公司, 有限公司, Zhejiang Medicine Co., 有限公司, Zhejiang NHU Co. 有限公司, 除其他外. These companies prioritize vitamin D3 as a premium ingredient due to its stability, longer shelf life, and versatility in various product forms. New vendors may offer opportunities for partnerships or collaborations. Online engagement and e-commerce channels are essential for lead generation and improving the end-user experience.

报告范围

To analyze and forecast the market size of the global vitamin d market.
To classify and forecast the global vitamin d market based on analog, 形式, 应用, 最终用户, 地理.
To identify drivers and challenges for the global vitamin d market.
检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global vitamin d market.
To identify and analyze the profile of leading players operating in the global vitamin d market.

为什么选择这份报告

Gain a reliable outlook of the global vitamin d market forecasts from 2023 到 2029 跨场景.
确定投资的增长领域.
通过公司简介和市场数据领先于竞争对手.
Excel 格式的跨场景分析易用性的市场预估.
三个月的战略咨询和研究支持.
为单用户许可证提供打印验证.